Hansa Medical (HMED) Starts Presentation at LD Micro Conference

Hansa Medical (NASDAQ: HMED) is a biopharmaceutical company that concentrates on novel immunomodulatory enzymes. Currently in clinical development, the company’s leading project, IdeS, is an antibody-degrading enzyme with the potential use in transplantation and rare autoimmune diseases.Other projects include HBP (a market introduced diagnostic marker for severe sepsis) and EndoS (an antibody-modulating bacterial enzyme in pre-clinical development). Hansa Medical is based in Lund, Sweden. For more information, visit the company’s website at www.hansamedical.com.